Search
AxoGen Inc
AXGNAdd to Watchlist
44.840USD
+0.270+0.61%
Close 06/18, 16:00（ET）Quotes delayed by 15 min
2.38BMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated: 2026-06-18The current earnings forecast score of AxoGen Inc is 8.40, ranking 37 out of 203 in the Healthcare Equipment & Supplies industry. The average price target is 36.00, with a high of 40.00 and a low of 27.00.
Analyst Rating
Based on
10
analysts
Buy
Current Rating
50.700
Target Price
+13.07%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
94
Total
3
Median
7
Average
Company name
Ratings
Analysts
AxoGen Inc
AXGN
10
Boston Scientific Corp
BSX
37
Intuitive Surgical Inc
ISRG
35
Edwards Lifesciences Corp
EW
34
Thermo Fisher Scientific Inc
TMO
30
Veeva Systems Inc
VEEV
30
1
2
3
...
19
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
FAQs
What is AxoGen Inc's expected revenue for the next quarter?
AxoGen Inc's expected revenue is 66.99M.
What is AxoGen Inc's price target?
Analysts forecast that AxoGen Inc's price target is USD 36.00, with the highest forecast at USD 40.00 and the lowest forecast at USD 27.00.
How have AxoGen IncAXGN's recent earnings per share performed?
The market expectation was USD -0.38, while AxoGen IncAXGN's earnings per share (EPS) for the previous quarter was USD -0.28. EPS for the next quarter is expected at USD 0.12.
What is the analyst rating for AxoGen Inc?
Based on the ratings of AxoGen Inc's stock from 10 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.
